Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover PK and palatability study of glycopyrronium bromide oral solution versus Cuvposa
2013-002557-30Phase 4
- Sponsor
- Proveca
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of glycopyrronium in hypersalivation (2 arms), sponsored by Proveca. Primary endpoint: Pharmacokinetic comparison of glycopyrronium bromide oral solutions.
02
Drugs
glycopyrronium
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2013-002557-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002557-30.